Results 301 to 310 of about 149,099 (355)

Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome

open access: yesCell Death and Disease, 2019
Propofol infusion syndrome (PRIS) is an uncommon life-threatening complication observed most often in patients receiving high-dose propofol. High-dose propofol treatment with a prolonged duration can damage the immune system.
Lingbin Sun   +2 more
exaly   +2 more sources

Effects of propofol on the development of cancer in humans

open access: yesCell Proliferation, 2020
Cancer is one of most the significant threats to human health worldwide, and the primary method of treating solid tumours is surgery. Propofol, one of the most widely used intravenous anaesthetics in surgery, was found to be involved in many cancer ...
Xueqiong Zhu
exaly   +2 more sources

Propofol

2008
The hypnotic agent propofol has pharmacokinetic characteristics that allow for rapid onset and offset of drug effect and fast elimination from the body. Elderly patients show a greater sensitivity to the hypnotic effect of propofol. The drug is extensively metabolized in the liver through the cytochrome P450 system and glucuronidation, with potential ...
Vanlersberghe, C., Camu, Fréderic
openaire   +3 more sources

Propofol and the electroencephalogram

Clinical Neurophysiology, 2010
Propofol is an emulsion formulation of 2,6 diisopropylphenol developed in 1975. Widely recognized, it offers beneficial effects compared with other sedative drugs. Propofol is used in several clinical situations including multiple surgical procedures and critical-care medical conditions.
Andrew J. Cole   +2 more
openaire   +3 more sources

The effectiveness of a low-dose esketamine versus an alfentanil adjunct to propofol sedation during endoscopic retrograde cholangiopancreatography: A randomised controlled multicentre trial.

European Journal of Anaesthesiology, 2019
BACKGROUND Endoscopic retrograde cholangiopancreatography (ERCP) is one of the most complex gastrointestinal endoscopic procedures. Currently, it is still unclear which sedation regimen best facilitates an ERCP.
S. Eberl   +6 more
semanticscholar   +1 more source

The pharmacology of propofol

Journal of Clinical Anesthesia, 1989
A review of the pharmacology of propofol, a new IV anesthetic agent, is presented. Solubilized in a soybean emulsion, propofol is one of a series of sterically hindered phenols that exhibit anesthetic activity. Induction of anesthesia with propofol may be associated with pain on injection, apnea, and a reduction in arterial blood pressure (BP) and ...
Mark A. Skues, Cedric Prys-Roberts
openaire   +3 more sources

The Effect of Propofol and Dexmedetomidine Sedation on Norepinephrine Requirements in Septic Shock Patients: A Crossover Trial

Critical Care Medicine, 2019
Objectives: Propofol-based sedation may increase hemodynamic instability by decreasing vascular tone and venous return. Incremental exogenous catecholamines doses may be required to counteract such effects, aggravating the deleterious effects of ...
A. Morelli   +12 more
semanticscholar   +1 more source

Comparison of Propofol‐Lipuro with propofol mixed with lidocaine 10 mg on propofol injection pain

Anaesthesia, 2004
SummaryA common drawback of propofol is pain on injection and lidocaine is commonly mixed with propofol to reduce its incidence and severity. We conducted a randomised, prospective, double‐blind study to compare injection pain following the administration of two different formulations of propofol in 200 unpremedicated ASA I–III adult patients scheduled
A. McCluskey, M. S. Abdul-Latif, E. Kam
openaire   +3 more sources

Home - About - Disclaimer - Privacy